Creative Planning Karyopharm Therapeutics Inc. Transaction History

Creative Planning

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.15 - $8.37 $6,225 - $12,554	-1,500 Reduced 11.45%	11,600 $52,000
Q4 2021 Feb 11, 2022	SELL	$5.21 - $8.61 $15,630 - $25,830	-3,000 Reduced 18.63%	13,100 $84,000
Q2 2021 Aug 04, 2021	SELL	$8.11 - $11.11 $151,592 - $207,668	-18,692 Reduced 53.72%	16,100 $166,000
Q1 2021 Apr 30, 2021	SELL	$9.85 - $17.69 $180,501 - $324,169	-18,325 Reduced 34.5%	34,792 $366,000
Q4 2020 Jan 29, 2021	BUY	$14.15 - $17.19 $501,546 - $609,299	35,445 Added 200.57%	53,117 $822,000
Q3 2020 Nov 05, 2020	BUY	$14.14 - $19.71 $249,882 - $348,315	17,672 New	17,672 $258,000
Q4 2019 Jan 30, 2020	SELL	$9.23 - $19.67 $1.88 Million - $4.01 Million	-203,950 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$5.66 - $11.85 $1.15 Million - $2.42 Million	203,950 New	203,950 $1.96 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $52.7M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.